Navigation Links
Varian Medical Systems Schedules Investor Meeting at ASTRO in Miami Beach, FL
Date:8/23/2011

PALO ALTO, Calif., Aug. 23, 2011 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) will hold an investor event on Tuesday, October 4, at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Miami Beach.  Investors and members of the financial community are invited to join senior management for a tour of the company's exhibition at ASTRO.

Varian will host a meeting with management, beginning with breakfast at 7:00 a.m. and presentations at 7:30 a.m. on Tuesday at the Loews Miami Beach Hotel, 1601 Collins Ave. Miami, in the Americana Salon Meeting Room, 2nd Floor, Main Tower.  The presentations will be followed by a tour of Varian's ASTRO booth at the Miami Beach Convention Center, Booth #1825 – from 9 a.m. to 10 a.m.  

Management presentations will focus on advances in radiotherapy and radiosurgery as well as new technologies and products within the company's Oncology Systems, and emerging businesses.  Management will include: Varian Medical Systems' CEO and President Tim Guertin; Executive Vice President and Oncology Systems President Dow Wilson; Oncology Service Vice President Kolleen Kennedy; Senior Vice President and CFO Elisha Finney; Vice President Emerging Businesses Lester Boeh; and Investor Relations Vice President Spencer Sias.

Attendees are requested to RSVP for the meeting and/or booth tour, by clicking on: http://varian.mediaroom.com/index.php?s=101, or by contacting Anne Rambo at (650) 424-5834, or by e-mail: anne.rambo@varian.com.  Please RSVP by Tuesday, September 27, 2011.  

The meeting and presentation will be webcast beginning at 7:30 a.m. pacific time.  To access the webcast, click on http://investors.
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... LAS VEGAS , July 30, 2014  DigiPath, ... provider that is expanding into the cannabis testing and ... development in its business and affairs not previously disclosed ... for the recent unusual market action. "We ... securities over the last three trading days," said ...
(Date:7/30/2014)... , July 30, 2014 /PRNewswire-iReach/ -- This ... Global and Chinese Heparin sodium (CAS 9041-08-1) & ... the basic information of Heparin sodium (CAS 9041-08-1) ... and manufacturing technology. The report then explores global ... 9041-08-1) & calcium (CAS 37270-89-6) listing their product ...
(Date:7/30/2014)... , July 30, 2014  PDL BioPharma, Inc. ... company management will participate in the Jefferies 2014 Boston ... , Massachusetts. The conference will occur on August 6, 2014 ... BioPharma, Inc. PDL BioPharma manages a portfolio ... Queen et al. antibody humanization patents and license agreements ...
Breaking Medicine Technology:DigiPath No New Corporate Developments 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit 2
(Date:7/30/2014)... 2014 Today, Gen. Arthur T. Dean, ... America (CADCA) , the nation’s leading substance abuse prevention ... New York Times Editorial Board’s call for ... , “CADCA is disappointed in the New York ... national marijuana legalization. The move is shortsighted and completely ...
(Date:7/30/2014)... 30, 2014 (HealthDay News) -- Clues to whether a person ... blood test, a new study suggests. Chemical changes to ... may help spur suicidal thoughts and behaviors, the study,s authors ... alert doctors to a patient,s risk for suicide, they said. ... we have been stymied in our prevention efforts because we ...
(Date:7/30/2014)... Scientists in Manchester have identified a protein that could ... from a treatment that makes radiotherapy more effective, according ... of Cancer (BJC). , The team from The ... found that patients whose bladder tumour had high levels ... benefit from having carbogen oxygen mixed with carbon ...
(Date:7/30/2014)... with depression as preschoolers are likely to suffer from ... shows. , Depressed preschoolers were 2.5 times more likely ... school than kids who were not depressed at very ... of Medicine in St. Louis. , Their study is ... Journal of Psychiatry . , "It,s the same old ...
(Date:7/30/2014)... The Europe commercial aviation actuation system market ... is expected to reach $1,686.72 million by 2019 at ... an exclusive range of opportunities and challenges which will ... has seen slumps in the past, yet the sector ... to its long-term growth rate of approximately 5 % ...
Breaking Medicine News(10 mins):Health News:CADCA Responds to New York Times Editorial Board's Call for Marijuana Legalization 2Health News:Could a Blood Test Predict Suicide Risk? 2Health News:Could a Blood Test Predict Suicide Risk? 3Health News:Scientists pinpoint bladder cancer patients who could benefit from 'tumor-softening' treatment 2Health News:Many depressed preschoolers still suffer in later school years 2Health News:Many depressed preschoolers still suffer in later school years 3Health News:Europe Aviation Actuation System Market is Expected to Reach $1,686.72 Million in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Aviation Actuation System Market is Expected to Reach $1,686.72 Million in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Aviation Actuation System Market is Expected to Reach $1,686.72 Million in 2019 - New Report by MicroMarket Monitor 4
... to donation , , WEDNESDAY, Jan. 28 (HealthDay News) -- Americans ... tend to lead long, healthy lives themselves. , That,s the ... , "Their lifespan is comparable to others of the same ... N. Ibrahim, an associate professor of medicine at the University ...
... (NYSE: NTY ) ( www.NBTY.com ), a leading ... for the fiscal first quarter ended December 31, 2008.For the ... $661 million compared to $511 million for the fiscal first ... or 29%. Included in this total are net sales ...
... at The Medical College of Wisconsin to help prevent ... one of eight chosen by the Centers for Disease ... Compendium of Evidence-based HIV Prevention Interventions. To be included, ... STD-related risk behaviors, or promote safer behaviors. ...
... 28 CCA Industries, Inc. ... that the Board of Directors declared ... the 1st Quarter ending February 28, ... record February 3, 2009 and payable ...
... PRINCETON, N.J., Jan. 28 Covance Inc. (NYSE: ... December 31, 2008 of $0.72 per diluted share. For ... from $2.71 in 2007. Excluding the gain on sale ... share grew 14.5% to $3.03 in 2008 from $2.65 in ...
... PHILADELPHIA, Jan. 28 Leading Philadelphia lawyer Robert Spinelli ... Texas attorney Aaron DeLuca of DeLuca & Nemeroff LLP ... education for attorneys featuring doctors, trial attorneys and judges, ... event, titled "Introduction of General & Specific Causation Evidence ...
Cached Medicine News:Health News:Most Kidney Donors Lead Long, Healthy Lives 2Health News:Most Kidney Donors Lead Long, Healthy Lives 3Health News:NBTY Reports First Quarter Results 2Health News:NBTY Reports First Quarter Results 3Health News:NBTY Reports First Quarter Results 4Health News:NBTY Reports First Quarter Results 5Health News:NBTY Reports First Quarter Results 6Health News:NBTY Reports First Quarter Results 7Health News:NBTY Reports First Quarter Results 8Health News:NBTY Reports First Quarter Results 9Health News:NBTY Reports First Quarter Results 10Health News:NBTY Reports First Quarter Results 11Health News:NBTY Reports First Quarter Results 12Health News:NBTY Reports First Quarter Results 13Health News:NBTY Reports First Quarter Results 14Health News:NBTY Reports First Quarter Results 15Health News:NBTY Reports First Quarter Results 16Health News:Medical College of Wisconsin recognized for AIDS intervention research 2Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 2Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 3Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 4Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 5Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 6Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 7Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 8Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 9Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 10Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 11Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 12Health News:Toxic Causation Training Day for Attorneys 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: